Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARγ, but not cytokine production, by human monocyte-macrophages

Atherosclerosis

Volumn 168, Issue 2, 2003, Pages 271-282

  Kavanagh, Ian C ^a   Symes, Carole E ^a   Renaudin, Pauline ^a   Nova, Esther ^a   Mesa, Maria Dolores ^a   Boukouvalas, George ^a   Leake, David S ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Atherosclerosis; Cytokine; Monocyte; Oxidized LDL; Scavenger receptor

Indexed keywords

CD36 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

EID: 0037497959     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00148-5     Document Type: Article

References (38)

1. Febbraio M., Podrez E.A., Smith J.D., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105:2000;1049-1056.
2. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 87:1996;2020-2028.
3. Nagy L., Tontonoz P., Alvarez J.G.A., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell. 93:1998;229-240.
4. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
5. Ricote M., Li A.C., Wilson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage function. Nature. 391:1998;79-82.
6. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPARγ dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nat. Med. 7:2001;48-52.
7. Chinetti G., Lestavel S., Bocher V., et al. PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 7:2001;53-58.
8. Patel L., Charlton S.J., Marshall I.C., et al. PPARγ is not a critical mediator of primary monocyte differentiation or foam cell formation. Biochem. Biophys. Res. Commun. 290:2002;707-712.
9. Jiang C., Ting A.T., Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
10. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., et al. Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNFα responses of macrophages to lipopolysaccharide in vitro or in vivo. J. Immunol. 164:2000;1046-1054.
11. 2 inhibits the β2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor-γ ligation. J. Immunol. 163:1999;6187-6192.
12. Ross R. Mechanisms of disease - atherosclerosis - an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
13. Berliner J.A., Territo M.C., Sevanian A., et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
14. Hamilton T.A., Major J.A., Chisolm G.M. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J. Clin. Invest. 95:1995;2020-2027.
15. Brand K., Banka C.L., Mackman N., Terkeltaub R.A., Fan S.-T., Curtiss L.K. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler. Thromb. Vasc. Biol. 14:1994;790-797.
16. Hamilton T.A., Ma G., Chisolm G.M. Oxidized low-density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:1990;2343-2350.
17. Mikita T., Porter G., Lawn R.M., Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J. Biol. Chem. 276:2001;45729-45739.
18. Glass C.K., Witzum J.L. Atherosclerosis: the road ahead. Cell. 104:2001;503-516.
19. Rice-Evans C., Leake D.S., Bruckdorfer K.R., Diplock A.T. Practical approaches to low density lipoprotein oxidation - whys wherefores and pitfalls. Free Radic. Res. 25:1996;285-311.
20. Yoshida H., Quehenberger O., Kondratenko N., Green S., Steinberg D. Minimally oxidized low-density lipoprotein increases expression of the scavenger receptor A, CD36 and macrosialin in resident mouse peritoneal macrophages. Arterioscler. Thromb. Vasc. Biol. 18:1998;794-802.
21. Siow R.C.M., Richards J.P., Pedley K.C., Leake D.S., Mann G. Vitamin C protects human vascular smooth muscle cells against apoptosis by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler. Thromb. Vasc. Biol. 19:1999;2387-2394.
22. Gomez-Munoz A., Martens J.S., Steinbrecher U.P. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. Arterioscler. Thromb. Vasc. Biol. 20:2000;135-143.
23. El-Saadani M., Esterbauer H., El-Sayed M., Gohe M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630.
24. Borenfreund E., Babich H., Martinalguacil N. Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev. Biol. 20:1990;1030-1034.
25. Watson A.D., Leitinger N., Navab M., et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:1997;13597-13607.
26. Leitinger N., Tyner T.R., Oslund L., et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96:1999;12010-12015.
27. Subbanagounder G., Leitinger N., Schwenke D.C., et al. Determinants of bioactivity of oxidized phospholipids-specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20:2000;2248-2254.
28. Carpenter K.H., Wilkins G.M., Fussell B., Ballantine J.A., Taylor S.E., Mitchinson M.J., Leake D.S. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304:1994;625-633.
29. Dominaitiene R., Lindgren S., Janciauskiene S. Effects of differentially oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro. In Vitro Molec. Toxicol. 14:2001;83-97.
30. Wang T., Yu W.-G., Powell W.S. Formation of monohydroxy derivatives of arachidonic acid, linoleic acid and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells. J. Lipid Res. 33:1992;525-537.
31. Fajas L., Auboeuf D., Raspe E., et al. The organization, promoter analysis and expression of the human PPARγ gene. J. Biol. Chem. 272:1997;18779-18789.
32. Chung S.W., Kang B.Y., Kim S.Y., Pak Y.K., Cho D., Trincheri G., Kim T.S. Oxidized low-density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor gamma and nuclear factor kappa B. J. Biol. Chem. 275:2000;32681-32687.
33. Sato O., Kuriki C., Fukui Y., Motojima K. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α and γ ligands. J. Biol. Chem. 277:2002;15703-15711.
34. Stengel D., Antonucci M., Arborati M., Hourton D., Griglio S., Chapman M.J., Ninio E. Expression of PAF receptor in human monocyte-derived macrophages is down-regulated by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17:1997;954-962.
35. Hourton D., Delerive P., Stankova J., Staels B., Chapman A.J., Ninio E. Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor α down-regulate platelet-activating factor receptor expression in human macrophages. Biochem. J. 354:2001;225-232.
36. Marx N., Sukhova G., Murphy C., Libby P., Plutzky J. Macrophages in human atheroma contain PPARγ. Differentiation-dependent peroxisomal proliferator-activated receptor γ expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:1998;17-23.
37. Caspar-Baugil S., Tkaczuk J., Haure M.-J., et al. Mildly oxidized low-density lipoproteins decrease early production of interleukin-2 and nuclear factor kB binding to DNA in activated T-lymphocytes. Biochem. J. 337:1999;269-274.
38. Alcouffe J., Caspar-Bauguil S., Garcia V., Salvayre R., Thomsen M., Benoist H. Oxidized low density lipoproteins induce apoptosis in PHA-activated peripheral blood mononuclear cells and in the Jurkat cell line. J. Lipid Res. 40:1999;1200-1210.